Cas:62484-28-0 2,4-dichloro-7,8-dimethylquinazoline manufacturer & supplier

We serve Chemical Name:2,4-dichloro-7,8-dimethylquinazoline CAS:62484-28-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,4-dichloro-7,8-dimethylquinazoline

Chemical Name:2,4-dichloro-7,8-dimethylquinazoline
CAS.NO:62484-28-0
Synonyms:Quinazoline,2,4-dichloro-7,8-dimethyl;7,8-Dimethyl-2,4-dichlorchinazolin;2,4-dichloro-7,8-dimethyl-quinazoline
Molecular Formula:C10H8Cl2N2
Molecular Weight:227.09000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:25.78000
Exact Mass:226.00600
LogP:3.55340

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Quinazoline,2,4-dichloro-7,8-dimethyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-dichloro-7,8-dimethyl-quinazoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7,8-Dimethyl-2,4-dichlorchinazolin Use and application,2,4-dichloro-7,8-dimethyl-quinazoline technical grade,usp/ep/jp grade.


Related News: The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). 4-Bromo-2-ethynylpyridine manufacturers The growing use of biocatalysis in pharmaceutical chemistry promises to deliver on this need, while also offering substantial cost savings and faster time to market for urgently needed therapeutics. (4aR,8aS)-3-Fluorooctahydro-2H-chromene suppliers Regulators approved the shot in May but paused the deployment amid lingering concerns about blood clots. Japan has so far relied vaccines made by Pfizer Inc (PFE.N) and Moderna Inc (MRNA.O) in its inoculation push. boron phosphate vendor & factory.